.png){kind=icon}
Return
Microbial engineering for shikimate biosynthesis
.png){kind=icon}
PRE
AI
DOI：10.1016/j.enzmictec.2023.110306.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Shikimate, a precursor to the antiviral drug oseltamivir (Tamiflu & REG;), can influence aromatic metabolites and finds extensive use in antimicrobial, antitumor, and cardiovascular applications. Consequently, various strategies have been developed for chemical synthesis and plant extraction to enhance shikimate biosynthesis, potentially impacting environmental conditions, economic sustainability, and separation and purification processes. Mi-crobial engineering has been developed as an environmentally friendly approach for shikimate biosynthesis. In this review, we provide a comprehensive summary of microbial strategies for shikimate biosynthesis. These strategies primarily include chassis construction, biochemical optimization, pathway remodelling, and global regulation. Furthermore, we discuss future perspectives on shikimate biosynthesis and emphasize the importance of utilizing advanced metabolic engineering tools to regulate microbial networks for constructing robust mi-crobial cell factories.
Keywords:
Shikimate biosynthesis
Chassis construction
Biochemical strategy
Pathway remold
Global regulation
Journal
IF:
3.7
Papers:
5.4K
Citations:
10.0K
Organization
Cited Papers
ShareSave
ShareSaveShareSaveA Circular Bioeconomy with Biobased Procucts from CO2 Sequestration.png)
TRENDS IN BIOTECHNOLOGY
TRENDS IN BIOTECHNOLOGYIF14.9
PREAI
ShareSaveShareSaveGlobal Rebalancing of Cellular Resources by Pleiotropic Point Mutations Illustrates a Multi-scale Mechanism of Adaptive EvolutionCELL SYSTEMS
OAAI
CELL SYSTEMSIF7.7
OAAIShareSave
View more